Literature DB >> 12127149

Aggresome formation in neuropathy models based on peripheral myelin protein 22 mutations.

Mary C Ryan1, Eric M Shooter, Lucia Notterpek.   

Abstract

Alterations in peripheral myelin protein 22 (PMP22) gene expression are associated with demyelinating peripheral neuropathies. Overexpression of wild type (wt) PMP22 or inhibition of proteasomal degradation lead to the formation of aggresomes, intracellular ubiquitinated PMP22 aggregates. Aggresome formation has now been observed with two mutant PMP22s, the Tr- and TrJ-PMP22 when the proteasome is inhibited. The formation of these aggresomes required intact microtubules and involved the recruitment of chaperones, including Hsp40, Hsp70, and alphaB-crystallin. Spontaneously formed ubiquitinated PMP22 aggregates were also observed in Schwann cells of homozygous TrJ mice. Significant upregulation of both the ubiquitin-proteasomal and lysosomal pathways occurred in affected nerves suggesting that two pathways of PMP22 degradation are present. Thus, the presence of aggresomes appears to be a common finding in neuropathy models of PMP22 overexpression and of some point mutations known to cause neuropathy in mice and humans.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12127149     DOI: 10.1006/nbdi.2002.0500

Source DB:  PubMed          Journal:  Neurobiol Dis        ISSN: 0969-9961            Impact factor:   5.996


  39 in total

Review 1.  The delicate balance between secreted protein folding and endoplasmic reticulum-associated degradation in human physiology.

Authors:  Christopher J Guerriero; Jeffrey L Brodsky
Journal:  Physiol Rev       Date:  2012-04       Impact factor: 37.312

2.  Reduction of Dicer impairs Schwann cell differentiation and myelination.

Authors:  Jonathan D Verrier; Susan Semple-Rowland; Irina Madorsky; Joseph E Papin; Lucia Notterpek
Journal:  J Neurosci Res       Date:  2010-09       Impact factor: 4.164

3.  The formation of peripheral myelin protein 22 aggregates is hindered by the enhancement of autophagy and expression of cytoplasmic chaperones.

Authors:  Jenny Fortun; Jonathan D Verrier; Jocelyn C Go; Irina Madorsky; William A Dunn; Lucia Notterpek
Journal:  Neurobiol Dis       Date:  2006-12-13       Impact factor: 5.996

4.  Mutations associated with Charcot-Marie-Tooth disease cause SIMPLE protein mislocalization and degradation by the proteasome and aggresome-autophagy pathways.

Authors:  Samuel M Lee; James A Olzmann; Lih-Shen Chin; Lian Li
Journal:  J Cell Sci       Date:  2011-09-06       Impact factor: 5.285

5.  Curcumin treatment abrogates endoplasmic reticulum retention and aggregation-induced apoptosis associated with neuropathy-causing myelin protein zero-truncating mutants.

Authors:  Mehrdad Khajavi; Ken Inoue; Wojciech Wiszniewski; Tomoko Ohyama; G Jackson Snipes; James R Lupski
Journal:  Am J Hum Genet       Date:  2005-09-30       Impact factor: 11.025

Review 6.  Pathomechanisms of mutant proteins in Charcot-Marie-Tooth disease.

Authors:  Axel Niemann; Philipp Berger; Ueli Suter
Journal:  Neuromolecular Med       Date:  2006       Impact factor: 3.843

7.  Peripheral myelin protein 22 is regulated post-transcriptionally by miRNA-29a.

Authors:  Jonathan D Verrier; Pierre Lau; Lynn Hudson; Alexander K Murashov; Rolf Renne; Lucia Notterpek
Journal:  Glia       Date:  2009-09       Impact factor: 7.452

8.  Molecular architecture of myelinated peripheral nerves is supported by calorie restriction with aging.

Authors:  Sunitha Rangaraju; David Hankins; Irina Madorsky; Evgenia Madorsky; Wei-Hua Lee; Christy S Carter; Christiaan Leeuwenburgh; Lucia Notterpek
Journal:  Aging Cell       Date:  2009-02-23       Impact factor: 9.304

Review 9.  The PMP22 gene and its related diseases.

Authors:  Jun Li; Brett Parker; Colin Martyn; Chandramohan Natarajan; Jiasong Guo
Journal:  Mol Neurobiol       Date:  2012-12-07       Impact factor: 5.590

10.  Folding and Misfolding of Human Membrane Proteins in Health and Disease: From Single Molecules to Cellular Proteostasis.

Authors:  Justin T Marinko; Hui Huang; Wesley D Penn; John A Capra; Jonathan P Schlebach; Charles R Sanders
Journal:  Chem Rev       Date:  2019-01-04       Impact factor: 60.622

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.